Connect with us

BIOTECH

Axim Biotechnologies Inc (OTCMKTS:AXIM) Participated In The Pharmaceutical Sciences World Congress

Published

on

Axim Biotechnologies Inc (OTCMKTS:AXIM) reported that its CTO Lekhram Changoer presented the firm’s research at the 6th PSWC, held from May 21-24, 2017 in Stockholm. He presented under the program course on Drug Delivery and Targeting Sciences on two different topics. The first one was Chewing Gum; a unique delivery mechanism for hemp oil-derived Hemp formulation targeting Irritable Bowel Syndrome Patients; and second one was chewing Gum; a unique delivery mechanism for Hemp and THC formulations targeting spasticity and pain in Multiple Sclerosis patients.

This event was planned by International Pharmaceutical Federation, PSWC which is a major international global forum where scientists come at a common platform to network with key leaders from the pharma industry, government agencies, academia and public-private associations, and regulatory bodies.

The highlights

Earlier Axim reported that information on the firm’s bioavailability trial on Dronabinol in a regulated-release, handy chewing gum form is now accessible on National Institutes of Health online site. This clinical trial will pave the scientific base for company and its controlled-substance API associate to co-advance a dronabinol-based functional, regulated-release chewing gum offering.

The latest dronabinol chewing gum offering will be bioequivalent to Marinol®, and it will be used to assist treat patients with chemotherapy led vomiting and nausea and AIDS patients witnessing weight and appetite loss.

The clinical trial is currently in preparation stage and is projected to register 50 healthy, non-smoking female and male, aged between 18 – 55 years.

AXIM emphasis remains on the research, development and manufacturing of cannabis-based pharma, cosmetic and nutraceutical products. Its major products include a Hemp-based regulated release chewing gum CanChew®, which contains 50 mg of Hemp experiencing clinical trials in subjects with IBS. Another product is MedChew Rx, which is a combination Hemp and THC gum that is into clinical trials targeting spasticity and pain related with multiple sclerosis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized4 days ago

Top 15 Essential Oils + Health Benefits

Top 15 Essential Oils + Health Benefits Each and every essential oil contains compounds with unique healing and therapeutic benefits....

Uncategorized4 days ago

Using Hemp Oil in Cooking

Hemp oil has many advocates. The oil from hemp seeds is rich in omega-3 and omega-6 essential fatty acids. This makes...

Uncategorized1 week ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health3 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business3 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business3 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business3 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP3 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP3 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP3 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

Advertisement
Advertisement
Advertisement